[FATE] QoQ Quarter Result on 30-Sep-2021 [#Q3]

Stock
[FATE] Fate Therapeutics, Inc.
Announcement Date
04-Nov-2021
Financial Year
2021
Quarter
30-Sep-2021 [#Q3]
Profit Trend
QoQ- 21.45%
YoY- 26.20%
Quarter Report
FATE's Result
FATE's Financial Summary
View:
Show?
Quarter Result
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
Revenue 18,549 18,414 17,067 14,225 13,412 11,142 15,896 10.86%
PBT -76,105 -65,690 -68,621 -43,308 -55,133 -45,089 -53,112 27.18%
Tax -757 -8,777 -2,206 -11,315 8,354 -1,121 -861 -8.24%
NP -76,105 -56,913 -68,621 -43,308 -55,133 -45,089 -53,112 27.18%
Tax Rate - - - - - - - -
Total Cost 94,654 75,327 85,688 57,533 68,545 56,231 69,008 23.52%
Ratio Analysis
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
NP Margin -410.29 -309.07 -402.07 -304.45 -411.07 -404.68 -334.12 14.71%
Per Share
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
EPS -0.79 -0.59 -0.72 -0.45 -0.58 -0.48 -0.61 18.86%
EPS Diluted -0.79 -0.59 -0.72 -0.45 -0.58 -0.48 -0.61 18.86%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.